A detailed history of Veriti Management LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Veriti Management LLC holds 14,815 shares of ADPT stock, worth $84,149. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,815
Previous 14,873 0.39%
Holding current value
$84,149
Previous $53,000 41.51%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$3.37 - $5.12 $195 - $296
-58 Reduced 0.39%
14,815 $75,000
Q2 2024

Aug 02, 2024

BUY
$2.34 - $3.96 $769 - $1,302
329 Added 2.26%
14,873 $53,000
Q1 2024

Apr 19, 2024

BUY
$2.88 - $4.8 $41,886 - $69,811
14,544 New
14,544 $46,000

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $812M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Veriti Management LLC Portfolio

Follow Veriti Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Veriti Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Veriti Management LLC with notifications on news.